gelatin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-05-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of collagen peptides varies by country and intended use. In the United States, they are typically marketed as dietary supplements or food ingredients, and certain uses may be generally recognized as safe (GRAS) through self-affirmation or notification. In the European Union, collagen peptides from approved animal sources are considered food, not novel foods, if they have a history of consumption. Health claims linking collagen peptides to joint or skin benefits are not approved in the US or EU. Labeling must list the animal source and may state the protein content.
Manufacturing collagen peptides begins with collagen-rich raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage, which undergo washing, size reduction, and pretreatment to remove non-collagen proteins and fats. Extraction may use acid, alkali, or heat. Hydrolysis then breaks the collagen into smaller peptides, often with enzymes such as pepsin, papain, or alcalase. Process conditions of time, temperature, pH, and enzyme dose determine the final molecular weight distribution. After hydrolysis, the solution is filtered, concentrated, and dried into powder.
Molecular weight distribution is a central quality attribute because it influences solubility, viscosity, foaming, and sensory properties. High-performance size-exclusion chromatography with refractive index or multi-angle light scattering detection can estimate average molecular weight and polydispersity. The degree of hydrolysis is sometimes measured by quantifying free amino groups with trinitrobenzenesulfonic acid or o-phthalaldehyde. Results depend on calibration standards and mobile-phase conditions, so method details matter when comparing certificates of analysis. Reported values are operational rather than absolute unless the method is fully validated.
Collagen peptides are hygroscopic and can cake or lose flowability when exposed to moisture. Typical storage is in sealed containers at ambient temperature, away from direct sunlight and strong odors. High humidity and prolonged heat may increase Maillard browning, off-odors, or microbial risk. Food-grade specifications commonly set limits for moisture, ash, heavy metals, and total plate count. Stability studies often monitor appearance, moisture, molecular mass profile, and microbial counts over defined intervals.
| Property | Value | Notes |
|---|---|---|
| Protein content | ≥90% (dry basis) | Determined by Kjeldahl or Dumas; varies by grade |
| Moisture | ≤10% | Higher moisture reduces shelf life and promotes clumping |
| Heavy metals | Lead ≤2 mg/kg; arsenic ≤1 mg/kg | Limits vary by jurisdiction; tested by ICP-MS |
| Microbial limits | Total aerobic count ≤10^4 CFU/g | Typical specification for food-grade powders |
| Labeling | Hydrolyzed collagen or collagen peptides | Source animal must be declared in many markets |
Quality control for hydrolyzed collagen begins with identity testing and raw material traceability. Laboratories may verify protein content by Kjeldahl or combustion methods, and characterize molecular weight distribution using size-exclusion chromatography or gel electrophoresis. Amino acid analysis confirms the presence of glycine, proline, and hydroxyproline in expected proportions. Moisture, ash, and microbial limits are also monitored because powders can absorb water. These tests help distinguish hydrolyzed collagen from gelatin, whey, or plant protein ingredients.
Stability depends on moisture, temperature, and packaging. Dry powders are generally stable for months to years when kept sealed and cool, but heat and humidity can promote clumping, Maillard reactions, and off-flavors. Peptides with lower molecular weight may be more hygroscopic than longer-chain hydrolysates. Light exposure is less critical than moisture control for most commercial powders. Once a container is opened, repeated exposure to air can shorten usable shelf life.
Stability depends on moisture, temperature, oxygen, and packaging. Dry collagen peptide powders are generally stable when kept cool and dry, but humid conditions can cause clumping and microbial growth. Heat exposure may promote Maillard reactions if reducing sugars are present, altering color and flavor. Solutions are less stable than powders and may support microbial proliferation unless preserved or refrigerated; light exposure can also affect appearance over time. Shelf-life claims vary and should be supported by real-time or accelerated stability data.
Quality control for collagen peptides may include identity, purity, and contaminant testing. Identity can be supported by amino acid profile and hydroxyproline content; purity checks may examine moisture, ash, protein content, and peptide size range. Heavy metals, microbial counts, and residual solvents are relevant for materials intended for ingestion. Some suppliers use peptide fingerprinting or source-specific markers, though these methods are not universally standardized. Documentation such as certificates of analysis helps verify that a batch meets agreed specifications.
Analytical characterization of collagen peptides often begins with peptide size distribution. Size-exclusion chromatography can separate peptides by hydrodynamic volume, while mass spectrometry provides more detailed mass information. Amino acid analysis quantifies residues such as glycine, proline, and hydroxyproline. Hydroxyproline assays are widely used because this amino acid is uncommon in many other proteins; nitrogen content and ash values help assess purity and residual minerals. No single method captures all relevant properties, so laboratories commonly combine several techniques.
Collagen peptides are short chains of amino acids produced by hydrolyzing collagen, a structural protein found in skin, bone, and connective tissue. The hydrolysis process breaks the triple-helical collagen molecule into smaller fragments, typically ranging from two to twenty amino acids in length. This reduction in size increases solubility in water and improves absorption compared to intact collagen. The resulting material is a mixture of peptides rather than a single defined compound. Commercial sources include bovine hide, porcine skin, fish scales, and eggshell membrane.
The amino acid profile of collagen peptides is distinctive, with high proportions of glycine, proline, and hydroxyproline. These three residues make up roughly half of the total amino acid content in typical mammalian collagen. Hydroxyproline is formed by post-translational modification of proline and is uncommon in most other proteins. The presence of hydroxyproline serves as a marker for collagen-derived material in analytical testing. Peptide length and distribution depend on the hydrolysis conditions, including temperature, time, and enzyme or acid concentration.
Collagen peptides are typically sold as a powder that dissolves readily in cold or warm liquids. The powder is usually off-white to light yellow and has a mild taste, though some products may have a slight odor. Molecular weight distributions commonly range from about 1,000 to 5,000 daltons, but this varies by manufacturer and intended use. Smaller peptides are generally more soluble, while larger fragments may form viscous solutions. The material is hygroscopic and should be stored in sealed containers away from moisture and heat.
Commercial collagen peptides come from bovine hide and bone, porcine skin, fish skin and scales, and sometimes eggshell membrane. The raw material is cleaned, treated to remove non-collagen proteins and minerals, and then hydrolyzed using enzymes, acid, or alkali. Hydrolysis conditions influence peptide length, amino acid composition, and solubility. The dried product is typically a white to off-white powder with a mild odor. Collagen lacks tryptophan and is rich in glycine, proline, and hydroxyproline, though exact ratios depend on source and process.
Analytical characterization of collagen peptides usually begins with molecular weight distribution, measured by size-exclusion chromatography or gel permeation chromatography. Amino acid analysis quantifies glycine, proline, and hydroxyproline, while hydroxyproline itself serves as a marker for collagen-derived material. Degree of hydrolysis can be estimated by measuring free amino groups with reagents such as TNBS or OPA. Peptide sequencing by liquid chromatography–tandem mass spectrometry can identify specific fragments, but mixtures are complex. How peptide size and sequence relate to reported functional effects remains an active area of research rather than a settled matter.
Collagen is a structural protein found in skin, bone, tendon, and cartilage, where it forms triple-helical fibrils. Its amino acid sequence is dominated by repeating glycine-proline-hydroxyproline motifs. Collagen peptides are produced by hydrolyzing native collagen, which breaks the triple helix into shorter chains. The resulting material is water-soluble and has a lower molecular weight than intact collagen. The term covers a family of hydrolysates rather than a single defined compound.
British endocrinologist Albert T. W. Simeons proposed HCG as an adjunct to an ultra-low-calorie weight-loss diet (fewer than 500 calories). Simeons, while studying pregnant women in India on a calorie-deficient diet, and obese boys with pituitary issues (Frölich's syndrome) treated with low-dose HCG, observed that both lost fat rather than lean (muscle) tissue. He reasoned that HCG must be programming the hypothalamus to do this in the former cases in order to protect the developing fetus by promoting mobilization and consumption of abnormal, excessive adipose deposits. Simeons in 1954 published a book entitled Pounds and Inches, designed to combat obesity. Simeons, practicing at Salvator Mundi International Hospital in Rome, Italy, recommended low-dose daily HCG injections (125 IU) in combination with a customized ultra-low-calorie (500 cal/day, high-protein, low-carbohydrate/fat) diet, which was supposed to result in a loss of adipose tissue without loss of lean tissue. Other researchers did not find the same results when attempting experiments to confirm Simeons' conclusions, and in 1976 in response to complaints the FDA required Simeons and others to include the following disclaimer on all advertisements:
Abnormal basal metabolic rate refers to a high or low basal metabolic rate (BMR). It has numerous causes, both physiological (part of the body's normal function) and pathological (associated with disease). An abnormal basal metabolic rate is not necessarily indicative of disease; a number of physiological factors can alter the BMR by influencing cellular metabolic activity. For instance, males are more likely than females to have a high BMR, and in women, the BMR may rise to abnormal levels during pregnancy or lactation. An individual's BMR varies greatly with age: infants and children typically have a high BMR, required for growth, while the elderly have a low BMR. Tall, thin people have a higher BMR than their shorter counterparts, even with the same weight, due to the greater surface area of their skin. The metabolic rate also decreases during sleep and increases in exercise, and individuals who exercise regularly have a higher BMR than those who are sedentary. Environmental temperature also has an effect: the BMR is increased in both heat and cold.
In humans, it has been used to treat diarrhoea and enteritis caused by bacterial or protozoan infections, including traveler's diarrhoea, cholera, and bacteremic salmonellosis. In 2002, a journal article suggested its use in treatment of H. pylori infections in children. Furazolidone has also been used for giardiasis (due to Giardia lamblia), amoebiasis, and shigellosis, although it is not a first-line treatment. From the early 1970s, it has been used in China to treat peptic ulcers, where the mechanism is treatment of the causative Helicobacter pylori infection. As a veterinary medicine, furazolidone has been used with some success to treat salmonids for Myxobolus cerebralis infections. It has also been used in aquaculture. Since furazolidone is a nitrofuran antibiotic, its use in food animals is currently prohibited by the FDA under the Animal Medicinal Drug Use Clarification Act, 1994. Furazolidone is no longer available in the US. It is used to differentiate micrococci and staphylococci. It is believed to work by crosslinking of DNA.
The first studies measuring drugs in biological fluids were carried out to determine possible overdosing as part of the new science of forensic medicine/toxicology. Initially, nonspecific assays were applied to measuring drugs in biological fluids. These were unable to discriminate between the drug and its metabolites; for example, aspirin (c. 1900) and sulfonamides (developed in the 1930s) were quantified by the use of colorimetric assays. Antibiotics were quantified by their ability to inhibit bacterial growth. The 1930s also saw the rise of pharmacokinetics, and as such the desire for more specific assays. Modern drugs are more potent, which has required more sensitive bioanalytical assays to accurately and reliably determine these drugs at lower concentrations. This has driven improvements in technology and analytical methods. Some techniques commonly used in bioanalytical studies include:
Sources: en.wikipedia.org
The YES/YAS assay is performed in 96-well microtiter plates. Total assay time is usually 2–3 days, but faster protocols (18 hrs. exposure time) using induced cell lysis have been developed. Several yeast cell lines have been developed for the YES and YAS assay, both proprietary and publicly available. Commercial kits with all necessary ingredients and detailed instructions are also available. Substances with an activating or inhibitory effect on the estrogen and/or androgen receptor of organisms may interfere with reproduction, affect the metabolism and immune system and induce the formation of tumors. This assay is suitable for detecting numerous natural and synthetic hormonally active substances such as environmental toxins from everyday products, e.g. birth control pill ingredients (17α-ethinylestradiol), synthetic materials (bisphenol A, phthalates), pesticides (methoxychlorine) and non-ionic surfactants (alkylphenols). The test has a good reproducibility and concordance with literature data of in vivo or in vitro data.
Feoktist I. Bogoyavlenskiy (1933–1935) Vasiliy V. Evlampiev (1935–1939) Faizi F. Faizyllin (1958–1960) Boris A. Arbuzov (1941–1950) Arkadiy N. Pudovik (1950–1958) Faizi F. Faizyllin (1958–1960) Vera F. Toropova (1960–1965) Alexander I. Kostromin (1965–1968) Alexander I. Konovalov (1968–1972) Irina V. Konovalova (1972–1987) Galina A. Chmutova (1987–1992) Nikolai A. Ulakhovich (1992–2000) Vladimir I. Galkin (since 2000– until present) Department of Analytical Chemistry Department of High Molecular and Organoelement Compounds Department of Inorganic Chemistry Department of Organic Chemistry Department of Physical Chemistry Department of Chemical Education Department of Environmental Chemistry Department of Applied Chemistry Department of Stereochemistry Division for Analytical Chemistry Division for Inorganic Chemistry and Coordination chemistry Division for Organic Chemistry Division for Physical Chemistry Division for Organoelement Compounds Division for Stereochemistry Division for Applied Chemistry Division for Environmental Chemistry
The double helix is the dominant tertiary structure for biological DNA, and is also a possible structure for RNA. Three DNA conformations are believed to be found in nature, A-DNA, B-DNA, and Z-DNA. The "B" form described by James D. Watson and Francis Crick is believed to predominate in cells. James D. Watson and Francis Crick described this structure as a double helix with a radius of 10 Å and pitch of 34 Å, making one complete turn about its axis every 10 bp of sequence. The double helix makes one complete turn about its axis every 10.4–10.5 base pairs in solution. This frequency of twist (known as the helical pitch) depends largely on stacking forces that each base exerts on its neighbours in the chain. Double-helical RNA adopts a conformation similar to the A-form structure. Other conformations are possible; in fact, only the letters F, Q, U, V, and Y are now available to describe any new DNA structure that may appear in the future. However, most of these forms have been created synthetically and have not been observed in naturally occurring biological systems.
Sources: en.wikipedia.org
Anti-citrullinated protein antibodies (ACPAs) are autoantibodies (antibodies to an individual's own proteins) that are directed against peptides and proteins that are citrullinated. They are present in the majority of patients with rheumatoid arthritis. Clinically, cyclic citrullinated peptides (CCP) are frequently used to detect these antibodies in patient serum or plasma (then referred to as anti–citrullinated peptide antibodies). During inflammation, arginine amino acid residues can be enzymatically converted into citrulline residues in proteins such as vimentin, by a process called citrullination. If their shapes are significantly altered, the proteins may be seen as antigens by the immune system, thereby generating an immune response. ACPAs have proved to be powerful biomarkers that allow the diagnosis of rheumatoid arthritis (RA) to be made at a very early stage. In July 2010, the 2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria were introduced. These new classification criteria include ACPA testing, and overruled the "old" ACR criteria of 1987 and are adapted for early RA diagnosis.
There are many applications for AMS throughout a variety of disciplines. AMS is most often employed to determine the concentration of 14C, e.g. by archaeologists for radiocarbon dating. Compared to other radiocarbon dating methods, AMS requires smaller sample sizes (about 50 mg), while yielding extensive chronologies. MS technology has expanded the scope of radiocarbon dating. Samples ranging from 50,000 years old to 100 years old can be successfully dated using AMS, as other forms of mass spectrometry provide insufficient suppression of molecular isobars to resolve 13CH and 12CH2 from 14C atoms. Because of the long half-life of 14C, decay counting requires significantly larger samples. 10Be, 26Al, and 36Cl are used for surface exposure dating in geology. 3H, 14C, 36Cl, and 129I are used as hydrological tracers. Accelerator mass spectrometry is widely used in biomedical research. In particular, 41Ca has been used to measure bone resorption in postmenopausal women. List of accelerator mass spectrometry facilities Arizona Accelerator Mass Spectrometry Laboratory
Degradation of an amino acid often begins with transamination, in which its amino group is transferred to α-ketoglutarate, forming glutamate. This process involves transaminases, often the same enzymes used in amino acid synthesis. In many vertebrates, the amino group is subsequently released as ammonia and converted to urea via the urea cycle for excretion. However, amino acid degradation can result in uric acid or ammonia instead, depending on the organism. For example, serine dehydratase converts serine directly to pyruvate and ammonia. After removal of one or more amino groups, the remaining carbon skeleton of an amino acid can serve as a precursor for synthesizing other amino acids, be further metabolized for energy after conversion into intermediates of glycolysis (typically via gluconeogenesis) or of the citric acid cycle, or be used for fatty acid synthesis and storage as triacylglycerol. Amino acids are bidentate ligands, forming transition metal amino acid complexes.
Ca2+ currents through cardiomyocyte gap junctions mediate synchronized contraction of cardiac tissue. As a result, GCaMP expression in cardiomyocytes, both in vitro and in vivo, has been used to study Ca2+-influx-dependent excitation and contraction in zebrafish and mice. For instance, Tallini et al. (2006) expressed GCaMP2 in mouse embryos to show that, at embryonic day 10.5, electrical conduction was rapid in the atria and ventricles but slow in the atrioventricular canal. Chi et al. (2008) used a transgenic cardiac-specific GCaMP zebrafish line to image cardiomyocyte activation throughout the cardiac cycle; from their results, they characterized four developmental stages of the zebrafish cardiac conduction system and identified 17 novel mutations affecting cardiac conduction. However, uncontrolled expression of GCaMP leads to cardiac hypertrophy due to overexpression of the calmodulin motif, which interferes with intracellular calcium signaling. As a result, experiments using cardiac tissue should carefully control the level of GCaMP expression.
Sources: en.wikipedia.org
Size-exclusion chromatography is the standard method, often with refractive index or ultraviolet detection. Calibration uses known protein standards. SDS-PAGE can provide a rough range but is less precise.
No. In most countries they are regulated as food ingredients or dietary supplements. They cannot carry claims to treat or prevent disease.
Dry powder should be kept in sealed containers at ambient temperature, away from moisture and direct sunlight. High humidity can cause clumping and microbial growth. Liquid formulations may require refrigeration.
Purity is assessed through a combination of protein content, hydroxyproline, amino acid composition, and chromatographic profile. Moisture, ash, and microbial tests cover non-protein impurities and handling quality.